GlassScriptPhysician profile
Raymond Catania
NPI 1023094711
$1,373.87
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,133 · 2020: $240.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $322.97 | 2019-2020 | |
| Amgen INC. | $202.27 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $195.79 | 2019-2020 | |
| Pfizer INC. | $155.14 | 2019-2020 | |
| Amarin Pharma, INC. | $150.65 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $73.85 | 2019 | |
| Novartis Pharmaceuticals Corporation | $60.86 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $51.05 | 2019 | |
| Novo Nordisk INC | $38.08 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $28.74 | 2019 | |
| Medtronic Vascular, INC. | $19.92 | 2019 | |
| Biotronik INC. | $17.94 | 2019 | |
| Chiesi USA, INC. | $16.74 | 2019 | |
| Allergan, INC. | $14.98 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.86 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $12.03 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Catania listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.